RHEP
REGIONAL HEALTH PROPERTIES, INC
0.00 (0.00%)1.01USD0成交股數4.0M市值0.5本益比(近四季)0.1股價營收比+143.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 24.4M+143% | 21.2M+194% | 20.8M+267% | 15.1M+258% | 10.1M+133% | 7.2M+74% | 5.7M+25% | 4.2M+2% | 4.3M | 4.1M | 4.5M | 4.1M |
| 營業成本 | 6.1M | 4.5M | – | 2.5M | – | – | – | – | – | – | – | – |
| 毛利 | 18.4M | 16.7M | – | 12.7M | – | – | – | – | – | – | – | – |
| 毛利率 | 75.1% | 78.8% | – | 83.7% | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 6.7M | 6.5M | 3.7M | 3.7M | 2.4M | 2.2M | 1.3M | 1.2M | 1.2M | 1.6M | 1.1M | 1.3M |
| 營業利益 | −216K-57% | −702K+121% | 3.1M+470% | −594K+98% | −508K-337% | −318K+8% | 541K+240% | −300K-26% | 214K | −294K | 159K | −404K |
| 營業利益率 | -0.9% | -3.3% | 14.8% | -3.9% | -5.1% | -4.4% | 9.6% | -7.1% | 4.9% | -7.1% | 3.5% | -9.8% |
| 稅後淨利 | −791K-45% | −1.2M-3% | 2.7M-575% | 3.4M-444% | −1.4M+105% | −1.3M+31% | −568K+139% | −982K+1% | −706K | −962K | −238K | −973K |
| 淨利率 | -3.2% | -5.8% | 13.0% | 22.3% | -14.4% | -17.6% | -10.0% | -23.2% | -16.3% | -23.3% | -5.3% | -23.5% |
| 稀釋 EPS | -0.20-71% | -0.29-69% | 1.54-597% | 1.17-325% | -0.68+79% | -0.94+81% | -0.31-126% | -0.520% | -0.38 | -0.52 | 1.17 | -0.52 |
| 稀釋股數 | 3.9M | 3.9M | 2.8K | 3.1K | 2.1M | 2.0M | 1.9K | 1.9K | 1.8K | 1.8M | 1.9K | 1.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.7M | 1.1M | 3.0M | 1.0M | 400K | 500K | 582K | 500K | 700K | 800K | 1.0M | 1.4M |
| 應收帳款 | 10.3M | 10.1M | 8.0M | 7.7M | 4.4M | 3.6M | 3.4M | 2.0M | 1.8M | 1.5M | 1.4M | 2.0M |
| 存貨 | 1.5M | 1.6M | 1.4M | 1.4M | – | – | – | – | – | – | – | – |
| 總資產 | 68.0M | 67.3M | 67.8M | 72.2M | 60.1M | 59.3M | 60.5M | 60.1M | 61.3M | 61.2M | 62.2M | 64.0M |
| 有息負債 | 34.1M | 34.5M | 34.7M | 48.6M | 48.9M | 49.2M | 39.3M | 49.7M | 50.2M | 50.0M | 50.7M | 51.4M |
| 總負債 | 65.0M | 63.6M | 62.8M | 69.0M | 65.6M | 63.4M | 63.4M | 62.4M | 62.7M | 62.0M | 62.0M | 63.6M |
| 股東權益 | −1.7M | −962K | 349K | −1.5M | −5.5M | −4.2M | −2.9M | −2.4M | −1.4M | −734K | 185K | 387K |
| 負債比 | 95.6% | 94.5% | 92.6% | 95.6% | 109.1% | 107.0% | 104.8% | 104.0% | 102.3% | 101.2% | 99.7% | 99.4% |
| 淨現金(現金 − 有息負債) | −32.4M | −33.4M | −31.7M | −47.6M | −48.5M | −48.7M | −38.7M | −49.2M | −49.5M | −49.2M | −49.7M | −50.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −890K-477% | – | – | – | 236K-60% | – | – | – | 597K | – | – |
| 資本支出 | – | 364K | – | – | – | 65K | – | – | – | 55K | – | – |
| 自由現金流 | – | −1.3M-833% | – | – | – | 171K-68% | – | – | – | 542K | – | – |
| 折舊攤銷 | 757K | 722K | 711K | 547K | 403K | 402K | 563K | 474K | 514K | 511K | 517K | 526K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -5.9% | – | – | – | 2.4% | – | – | – | 13.1% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 53.2M
| Healthcare Services | 36.1M | 67.8% | +219.8% |
|---|---|---|---|
| Pharmacy Service | 11.7M | 22.1% | – |
| Real Estate | 5.4M | 10.1% | -23.7% |
產品／服務2025 年度 · 53.2M
| Health Care Patient Service | 36.1M | 67.8% | +219.8% |
|---|---|---|---|
| Pharmacy Revenues | 11.7M | 22.0% | – |
| Rental Revenue | 5.4M | 10.2% | -22.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 53.2M | +189.9% | 3.4M | 6.3% | 1.09 | −3.1M |
| FY2024 | 18.3M | +6.8% | −3.2M | -17.6% | -1.73 | 1.4M |
| FY2023 | 17.2M | -52.2% | −3.9M | -22.7% | 21.05 | 2.8M |
| FY2022 | 35.9M | +34.6% | −6.9M | -19.1% | -8.93 | −3.9M |
| FY2021 | 26.7M | +51.8% | −1.2M | -4.4% | -5.87 | 4.8M |
| FY2020 | 17.6M | -12.7% | −688K | -3.9% | -5.74 | 845K |
| FY2019 | 20.1M | -8.7% | 5.5M | 27.3% | -2.07 | 2.3M |
| FY2018 | 22.0M | – | −11.9M | -54.0% | -11.86 | 1.0M |